建立b型流感嗜血杆菌结合疫苗原液的鉴别方法
摘要
关键词
全文:
PDF参考
[1]Wen S, Feng D, Chen D, et al. Molecular epidemiology and evolution of Haemophilus influenzae [J]. Infect Genet Evol,2020,80:104205.
[2]Adams WG, Deaver KA, Cochi SL, et al. Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era [J].JAMA,1993,269:221.
[3]Anderson EC, Begg NT, Crawshaw SC, et al. Epidemiology of invasive Haemophilus influenzae infections in England and Wales in the pre-vaccination era (1990-2) [J].Epidemiol Infect,1995,115:89.
[4]Slack MPE, Cripps AW, Grimwood K, et al. Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use [J].Clin Microbiol Rev,2021,34:0002821.
[5]Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex [J].NEJM, 1991,324:1767.
[6]Chongmelaxme B, Hammanee M, Phooaphirak W, et al. Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review [J].JME,2017,20:1094.
[7]Peltola H, Käyhty H, Virtanen M, et al. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine[J].NEJM,1984,310:1561.
[8]Anderson P, Pichichero ME, Insel RA. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b [J].J Pediatr,1985,107: 346.
[9]Barbour mL, Booy R, Crook DW, et al.Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine [J].The Pediatric infectious disease journal.1993,12:478.
[10]中国药典2020年版.三部[S].2020: 95.
[11]Mäkelä PH, Takala AK, Peltola H, et al. Epidemiology of invasive Haemophilus influenzae type b disease [J]. JID,1992,165 Suppl1:2.
[12]Wilfert CM. Epidemiology of Haemophilus influenzae type b infections [J].PEDIATRICS,1990,85:631.
[13]WHO. Essential Programme on Immunization. WHO[EB/OL].https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization. Access Date:2024.11.07
[14]随海田,赵若颖,郭昱,等.中国4款未纳入国家免疫规划疫苗针对疾病负担及应用情况分析[J].中国病毒病杂志.2024,14:293.
[15]姚永鹏,张子昌,许可,等.新型ACYW135群脑膜炎球菌-白喉毒素无毒变异体结合疫苗的制备及其免疫原性评价[J].中国生物制品学杂志.2024,37:795.
[16]方国良,马波,杨丽,等.b型流感嗜血杆菌结合疫苗的稳定性评价[J].中国生物制品学杂志.2015,28:1008.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。